Clinton Bybee - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Impinj Inc (PI). Other recent insider transactions involving Impinj Inc (PI) include a net sale of 203,464 shares made by Diorio Chris Ph.d. , a net sale of 92,435 shares made by Jeffrey Dossett , and a net sale of 62,856 shares made by Cary Baker .

In summary, during the past 3 months, insiders sold 1,190,149 shares of Impinj Inc (PI) in total and bought 4,264,393 shares, with a net purchase of 3,074,244 shares. During the past 18 months, 2,539,064 shares of Impinj Inc (PI) were sold and 5,740,087 shares were bought by its insiders, resulting in a net purchase of 3,201,023 shares.

Impinj Inc (PI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 16,081 shares made by Christine Bellon , a net sale of 263,284 shares made by Giuseppe Ciaramella , and a net sale of 198,102 shares made by John M. Evans .

In summary, during the past 3 months, insiders sold 162,894 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 162,894 shares. During the past 18 months, 1,413,543 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413,543 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 494,544 shares made by Svf Endurance (cayman) Ltd , a net sale of 22,889 shares made by Phillip Pang , and a net sale of 55,500 shares made by George A Scangos .

In summary, during the past 3 months, insiders sold 20,337 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 20,337 shares. During the past 18 months, 715,280 shares of Vir Biotechnology Inc (VIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 715,280 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 29,606 shares made by Vicki L Sato , a net sale of 89,326 shares made by Alexander O. Schuth , and a net sale of 54,249 shares made by Carole Ho .

In summary, during the past 3 months, insiders sold 153,199 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 153,199 shares. During the past 18 months, 528,357 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 528,357 shares.

Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 42,622 shares made by David Roth , a net sale of 37,803 shares made by Jason Haas , and a net sale of 34,797 shares made by Chee Conley .

In summary, during the past 3 months, insiders sold 502,202 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net sale of 302,202 shares. During the past 18 months, 533,414 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 571,563 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Karuna Therapeutics Inc (KRTX). Other recent insider transactions involving Karuna Therapeutics Inc (KRTX) include a net sale of 55,000 shares made by Stephen K. Brannan , a net sale of 41,429 shares made by Jeffrey M Jonas , and a net sale of 1,500 shares made by Troy A. Ignelzi .

In summary, during the past 3 months, insiders sold 0 shares of Karuna Therapeutics Inc (KRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 97,929 shares of Karuna Therapeutics Inc (KRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,929 shares.

Karuna Therapeutics Inc (KRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net sale of 7,740 shares made by Richard Aranda , and a net purchase of 348,828 shares made by Faheem Hasnain .

In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,790 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 681,210 shares.

Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Twist Bioscience Corp (TWST). Other recent insider transactions involving Twist Bioscience Corp (TWST) include a net sale of 12,227 shares made by Dennis Cho , a net sale of 77,455 shares made by Emily M. Leproust , and a net sale of 22,574 shares made by Paula Green .

In summary, during the past 3 months, insiders sold 138,090 shares of Twist Bioscience Corp (TWST) in total and bought 0 shares, with a net sale of 138,090 shares. During the past 18 months, 186,804 shares of Twist Bioscience Corp (TWST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 186,804 shares.

Twist Bioscience Corp (TWST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 336,643 shares made by Edward H Myles , a net sale of 35,372 shares made by Mo Qatanani , and a net sale of 13,709 shares made by Caryn Parlavecchio .

In summary, during the past 3 months, insiders sold 1,980,509 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 1,980,509 shares. During the past 18 months, 2,129,751 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,579,493 shares were bought by its insiders, resulting in a net purchase of 4,449,742 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Unity Biotechnology Inc (UBX). Other recent insider transactions involving Unity Biotechnology Inc (UBX) include a net sale of 10,382 shares made by Anirvan Ghosh , a net sale of 599 shares made by Lynne Marie Sullivan , and a net sale of 381 shares made by Alexander Hieu Nguyen .

In summary, during the past 3 months, insiders sold 717 shares of Unity Biotechnology Inc (UBX) in total and bought 0 shares, with a net sale of 717 shares. During the past 18 months, 11,362 shares of Unity Biotechnology Inc (UBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,362 shares.

Unity Biotechnology Inc (UBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Quanterix Corp (QTRX). Other recent insider transactions involving Quanterix Corp (QTRX) include a net sale of 5,500 shares made by Laurie J Olson , a net purchase of 47,000 shares made by David R Walt , and a net purchase of 20,200 shares made by William P Donnelly .

In summary, during the past 3 months, insiders sold 0 shares of Quanterix Corp (QTRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,500 shares of Quanterix Corp (QTRX) were sold and 86,200 shares were bought by its insiders, resulting in a net purchase of 80,700 shares.

Quanterix Corp (QTRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Xtera Communications Inc (XCOMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xtera Communications Inc (XCOMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xtera Communications Inc (XCOMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of PhaseRx Inc (PZRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseRx Inc (PZRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseRx Inc (PZRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Juno Therapeutics Inc (JUNO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Juno Therapeutics Inc (JUNO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Juno Therapeutics Inc (JUNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Adesto Technologies Corp (IOTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adesto Technologies Corp (IOTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adesto Technologies Corp (IOTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 2,000 shares made by Elizabeth Barrett ,

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sage Therapeutics Inc (SAGE) were sold and 2,000 shares were bought by its insiders, resulting in a net purchase of 2,000 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 10,188 shares made by Washburn Theodore James Jr. , a net sale of 35,912 shares made by James William Burns , and a net sale of 64,534 shares made by Brian Goff .

In summary, during the past 3 months, insiders sold 45,066 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 45,066 shares. During the past 18 months, 295,120 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,120 shares.

Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Bellerophon Therapeutics Inc (BLPH). Other recent insider transactions involving Bellerophon Therapeutics Inc (BLPH) include a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi , and a net sale of 134,421 shares made by Puissance Capital Fund (gp) Llc .

In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,211,262 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,211,262 shares.

Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 18,777 shares made by Dulac Edward J Iii , a net sale of 4,725 shares made by Yuan Xu , and a net sale of 35,237 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 88,255 shares of Fate Therapeutics Inc (FATE) were sold and 44,630 shares were bought by its insiders, resulting in a net sale of 43,625 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in bluebird bio Inc (BLUE). Other recent insider transactions involving bluebird bio Inc (BLUE) include a net sale of 28,872 shares made by Andrew Obenshain , a net sale of 16,173 shares made by Thomas J Klima , and a net sale of 9,710 shares made by Richard A Colvin .

In summary, during the past 3 months, insiders sold 0 shares of bluebird bio Inc (BLUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 64,498 shares of bluebird bio Inc (BLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 64,498 shares.

bluebird bio Inc (BLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 57,750 shares made by Yvonne Greenstreet , a net sale of 11,986 shares made by Pushkal Garg , and a net sale of 7,321 shares made by Jeffrey V. Poulton .

In summary, during the past 3 months, insiders sold 13,052 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 13,052 shares. During the past 18 months, 262,180 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 262,180 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Illumina Inc (ILMN). Other recent insider transactions involving Illumina Inc (ILMN) include a net sale of 1,500 shares made by Susan H Tousi , a net purchase of 7,330 shares made by Jacob Thaysen , and a net sale of 315 shares made by Aimee L Hoyt .

In summary, during the past 3 months, insiders sold 0 shares of Illumina Inc (ILMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,815 shares of Illumina Inc (ILMN) were sold and 7,330 shares were bought by its insiders, resulting in a net purchase of 5,515 shares.

Illumina Inc (ILMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in 908 Devices Inc (MASS). Other recent insider transactions involving 908 Devices Inc (MASS) include a net purchase of 40,929 shares made by Kevin J. Knopp , a net sale of 28,427 shares made by Christopher D. Brown , and a net sale of 26,989 shares made by Griffith Joseph H. Iv .

In summary, during the past 3 months, insiders sold 0 shares of 908 Devices Inc (MASS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 69,719 shares of 908 Devices Inc (MASS) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 19,719 shares.

908 Devices Inc (MASS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net purchase of 1,818,181 shares made by Arch Venture Fund X Overage, L.p. , a net purchase of 1,818,181 shares made by Keith Crandell , and a net purchase of 1,818,181 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 300,000 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 300,000 shares. During the past 18 months, 803,758 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,650,785 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net sale of 58,020 shares made by Richard Klausner ,

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,020 shares of Lyell Immunopharma Inc (LYEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 58,020 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Neumora Therapeutics Inc (NMRA). Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 2,007,064 shares made by Kristina Burow , a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , and a net sale of 88,235 shares made by Robert A. Lenz .

In summary, during the past 3 months, insiders sold 110,023 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 110,023 shares. During the past 18 months, 210,023 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,083,810 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.